Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Robert Jenq
Sloan Kettering Inst Can Research, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Seres Therapeutics
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
See attached.
Microbiota-focused strategies to mitigate GVHD
Bone marrow transplantation (BMT) is an important treatment that can produce cures for many patients with blood cancers, but comes with the risk of developing graft-versus-host disease (GVHD), which can lead to life-threatening inflammation and organ failure. We present our discovery that a type of bacteria naturally residing in the intestine may protect against GVHD in patients, but that this bacteria commonly disappears during the BMT process. We propose studies to determine how it can protect against GVHD and develop strategies to prevent its loss.
Filed on June 20, 2016.
Tell us what you know about Robert Jenq's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Robert Jenq filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Robert Jenq | Sloan Kettering Inst Can Research | Conflict of Interest | Seres Therapeutics | $10,000 - $19,999 |
| Robert Jenq | Sloan Kettering Inst Can Research | Conflict of Interest | Seres Therapeutics | $0 - $4,999 |
| Robert Jenq | Sloan Kettering Inst Can Research | Conflict of Interest | Epiva Therapeutics | $0 - $4,999 |
| Robert Jenq | Sloan Kettering Inst Can Research | Conflict of Interest | Epiva Therapeutics | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.